Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-14
DOI
10.1038/srep17895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA)
- (2016) Kazuo Yudoh et al. Aging-US
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- Protein Prenylation: Enzymes, Therapeutics, and Biotechnology Applications
- (2014) Charuta C. Palsuledesai et al. ACS Chemical Biology
- An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
- (2014) Marco Demaria et al. DEVELOPMENTAL CELL
- Intratumoural inflammation and endocrine resistance in breast cancer
- (2014) Jill I Murray et al. ENDOCRINE-RELATED CANCER
- Cellular senescence: from physiology to pathology
- (2014) Daniel Muñoz-Espín et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Crucial Role for CDC42 in Senescence-Associated Inflammation and Atherosclerosis
- (2014) Takashi K. Ito et al. PLoS One
- Oral Lovastatin Attenuates Airway Inflammation and Mucus Secretion in Ovalbumin-Induced Murine Model of Asthma
- (2014) Chian-Jiun Liou et al. Allergy Asthma & Immunology Research
- HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin
- (2013) Sandra J. Hernandez-Vallejo et al. AGING CELL
- A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
- (2013) Ariel Pribluda et al. CANCER CELL
- p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
- (2013) Albert R. Davalos et al. JOURNAL OF CELL BIOLOGY
- Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
- (2013) K.-H. Kim et al. MOLECULAR AND CELLULAR BIOLOGY
- A complex secretory program orchestrated by the inflammasome controls paracrine senescence
- (2013) Juan Carlos Acosta et al. NATURE CELL BIOLOGY
- Glucocorticoids suppress selected components of the senescence-associated secretory phenotype
- (2012) Remi-Martin Laberge et al. AGING CELL
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Rho family GTPases
- (2012) Alan Hall BIOCHEMICAL SOCIETY TRANSACTIONS
- Statin use and risk of breast cancer: a meta-analysis of observational studies
- (2012) Krishna Undela et al. BREAST CANCER RESEARCH AND TREATMENT
- Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation
- (2012) Maria Carolina Florian et al. Cell Stem Cell
- Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions
- (2012) Elaina A Zverina et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
- (2012) Dipika Bansal et al. PLoS One
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
- (2011) T. P. Ahern et al. JNCI-Journal of the National Cancer Institute
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Senescent cells as a source of inflammatory factors for tumor progression
- (2010) Albert R. Davalos et al. CANCER AND METASTASIS REVIEWS
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing
- (2010) Joon-Il Jun et al. NATURE CELL BIOLOGY
- Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients
- (2009) L. M. McGlynn et al. CLINICAL CANCER RESEARCH
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
- (2009) Francis Rodier et al. NATURE CELL BIOLOGY
- Update on statin-mediated anti-inflammatory activities in atherosclerosis
- (2009) Fabrizio Montecucco et al. Seminars in Immunopathology
- Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
- (2008) Thomas Frogne et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
- (2008) Thomas Kuilman et al. CELL
- Cellular senescence in vivo: a barrier to tumorigenesis
- (2008) Alexandre Prieur et al. CURRENT OPINION IN CELL BIOLOGY
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started